Page last updated: 2024-10-21

7-nitroindazole and Idiopathic Parkinson Disease

7-nitroindazole has been researched along with Idiopathic Parkinson Disease in 13 studies

7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure

Research Excerpts

ExcerptRelevanceReference
"Treatment with mangiferin and 7-NI significantly increases locomotor parameters in 6-OHDA lesioned rats."1.72Effects of mangiferin and its combination with nNOS inhibitor 7-nitro-indazole (7-NI) in 6-hydroxydopamine (6-OHDA) lesioned Parkinson's disease rats. ( Chaudhary, MJ; Nath, R; Pal, R; Tiwari, PC, 2022)
"Chronic L-DOPA pharmacotherapy in Parkinson's disease is often accompanied by the development of abnormal and excessive movements known as L-DOPA-induced dyskinesia."1.35Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. ( Del-Bel, EA; Echeverry, MB; Padovan-Neto, FE; Tumas, V, 2009)
"The neuropathological hallmark of Parkinson's disease (PD) is the selective degeneration of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNc)."1.337-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study. ( Benigno, A; Crescimanno, G; Di Giovanni, G; Di Matteo, V; Esposito, E; Giuliano, DA; Pierucci, M, 2006)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's5 (38.46)29.6817
2010's4 (30.77)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Tiwari, PC1
Chaudhary, MJ1
Pal, R1
Nath, R1
Herrero, MT1
Yuste, JE1
Cuenca-Bermejo, L1
Almela, P1
Arenas-Betancur, L1
De Pablos, V1
Gonzalez-Cuello, A1
Del Bel, E1
Navarro-Zaragoza, J1
Fernández-Villalba, E1
Solís, O1
Espadas, I1
Del-Bel, EA2
Moratalla, R1
Bortolanza, M2
Cavalcanti-Kiwiatkoski, R1
Padovan-Neto, FE2
da-Silva, CA2
Mitkovski, M1
Raisman-Vozari, R1
Del-Bel, E2
Kumari, R1
Kumar, JB1
Luthra, PM1
Bariotto-Dos-Santos, KD1
Dos-Santos-Pereira, M1
Di Matteo, V2
Pierucci, M2
Benigno, A2
Crescimanno, G2
Esposito, E2
Di Giovanni, G2
Echeverry, MB1
Tumas, V1
Giuliano, DA1
Rajakumar, B1
Flumerfelt, BA1
Hrycyshyn, AW1
Rajakumar, N1
Haik, KL1
Shear, DA1
Hargrove, C1
Patton, J1
Mazei-Robison, M1
Sandstrom, MI1
Dunbar, GL1
Przedborski, S1
Jackson-Lewis, V1
Yokoyama, R1
Shibata, T1
Dawson, VL1
Dawson, TM1
Snyder, SH1

Other Studies

13 other studies available for 7-nitroindazole and Idiopathic Parkinson Disease

ArticleYear
Effects of mangiferin and its combination with nNOS inhibitor 7-nitro-indazole (7-NI) in 6-hydroxydopamine (6-OHDA) lesioned Parkinson's disease rats.
    Fundamental & clinical pharmacology, 2022, Volume: 36, Issue:6

    Topics: Animals; Male; Nitrites; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar

2022
7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate.
    Open biology, 2023, Volume: 13, Issue:5

    Topics: Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Levodopa; Parkinson Disease; Parkinsonian D

2023
Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
    Neurobiology of disease, 2015, Volume: 73

    Topics: Animals; Antiparkinson Agents; Benserazide; Cell Count; Corpus Striatum; Disease Models, Animal; Dop

2015
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
    Neurobiology of disease, 2015, Volume: 73

    Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Indazoles; Inflamma

2015
Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
    Neuroscience letters, 2015, Mar-04, Volume: 589

    Topics: Animals; Brain; Catalase; Dopamine; Female; Glutathione; Indazoles; Lipid Peroxidation; Motor Skills

2015
Antidyskinetic Effect of 7-Nitroindazole and Sodium Nitroprusside Associated with Amantadine in a Rat Model of Parkinson's Disease.
    Neurotoxicity research, 2016, Volume: 30, Issue:1

    Topics: Amantadine; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia,

2016
Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study .
    Annals of the New York Academy of Sciences, 2009, Volume: 1155

    Topics: Animals; Corpus Striatum; Indazoles; Male; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Oxidopami

2009
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.
    Neuroscience, 2009, Mar-31, Volume: 159, Issue:3

    Topics: Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; En

2009
7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study.
    Annals of the New York Academy of Sciences, 2006, Volume: 1089

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Indazoles

2006
Nitric oxide-containing neurons in long-term grafts in a rat model of Parkinson's disease.
    Cell transplantation, 2007, Volume: 16, Issue:5

    Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Choline; Disease Models, Animal; Female; In

2007
7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease.
    Experimental and clinical psychopharmacology, 2008, Volume: 16, Issue:2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Indazoles; Learni

2008
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, May-14, Volume: 93, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebellum; Corpus Striatum; Dopamine; Dopamine Agents; Enz

1996
No NO prevents parkinsonism.
    Nature medicine, 1996, Volume: 2, Issue:9

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Enzyme Inhi

1996